Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

12345678910

LONDON MARKET CLOSE: Stocks mixed and pound dips amid budget tax hints

4th Nov 2025 16:59

(Alliance News) - The FTSE 100 outperformed European and US peers on Tuesday, but sterling fell further, as Chancellor Rachel Reeves laid the groundwork for further tax rises in this month’s budget. Read More

LONDON BROKER RATINGS: Shore Capital cuts Next; Bernstein cuts Ryanair

4th Nov 2025 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: UBS starts Drax with 'sell'; WPP targets cut

31st Oct 2025 10:07

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET CLOSE: WPP woes keep lid on FTSE and pound extends falls

30th Oct 2025 17:09

(Alliance News) - The FTSE 100 extended its winning run to nine, recouping early hefty falls, despite fresh problems for advertising group, WPP. Read More

LONDON BROKER RATINGS: UBS cuts Ibstock; Deutsche Bank says 'buy' PHP

30th Oct 2025 09:56

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON BRIEFING: Shell launches new buyback; WPP cuts revenue outlook

30th Oct 2025 07:51

(Alliance News) - Shell launches new USD3.5 billion buyback, WPP cuts its outlook while Permanent TSB puts itself up for sale. Read More

LONDON MARKET CLOSE: Stocks mixed ahead of Fed call, Trump-Xi talks

29th Oct 2025 17:10

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, as the US Federal Reserve's interest rate decision comes closer. Read More

LONDON MARKET MIDDAY: FTSE 100 hits new record amid strong results

29th Oct 2025 12:10

(Alliance News) - Stock prices in London were higher at midday on Wednesday, as the FTSE 100 achieved a new record and outperformed European peers after healthy results for GSK and Next. Read More

LONDON MARKET OPEN: FTSE 100 hits high as Next and GSK raise guidance

29th Oct 2025 09:01

(Alliance News) - Stock prices in London opened higher on Wednesday and hit a new intra-day record after a swathe of well-received reports from Glencore, Next and GSK. Read More

GSK lifts sales and profit outlook as Specialty Medicines unit shines

29th Oct 2025 08:51

(Alliance News) - GSK PLC on Wednesday raised guidance after a strong third quarter, which saw sales in all three divisions beat expectations. Read More

LONDON BRIEFING: GSK ups 2025 outlook; Next sales beat guidance

29th Oct 2025 07:50

(Alliance News) - GSK raises its outlook for revenue and profit, Next ups its guidance as third quarter sales beat expectations, while Primary Health Properties' acquisition of Assura is cleared by the UK competition regulator. Read More

GSK strikes license deal with Empirico; gets cancer drug designation

28th Oct 2025 09:23

(Alliance News) - GSK on Tuesday said it will pay up to USD745 million, plus royalties, as part of a license deal with US biotechnology company Empirico Inc. Read More

LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'

27th Oct 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON MARKET OPEN: FTSE lags rally amid US-China trade optimism

27th Oct 2025 09:02

(Alliance News) - Stock prices in London were mixed on Monday morning, as the UK lagged a broader rally amid hopes of a trade deal between the US and China. Read More

GSK buys exclusive rights from Syndivia for ADC in prostate cancer

27th Oct 2025 08:52

(Alliance News) - GSK PLC on Monday announced an agreement with Syndivia that grants GSK exclusive worldwide rights to develop and commercialise a preclinical antibody-drug conjugate for metastatic castration-resistant prostate cancer. Read More

LONDON BRIEFING: HSBC expects USD1.1 billion hit from Madoff case

27th Oct 2025 07:51

(Alliance News) - HSBC sets aside USD1.1 billion for a Luxembourg court ruling related to the Bernard Madoff fraud case, while the UK competition regulator asks for remedies to approve the Greencore-Bakkavor merger. Read More

LONDON MARKET CLOSE: FTSE 100 up as soft US CPI clears way for Fed cut

24th Oct 2025 17:04

(Alliance News) - The FTSE 100 hit another record peak on Friday fuelled by weaker-than-expected US inflation data, a bunch of optimistic UK economic reports and strong results from NatWest. Read More

LONDON MARKET OPEN: FTSE edges up as retail sales beat forecasts

24th Oct 2025 09:23

(Alliance News) - Stock prices in London opened slightly higher on Friday, supported by stronger-than-expected UK retail sales data, while investors looked ahead to a slew of PMI releases and US inflation figures later in the day. Read More

GSK wins US FDA approval of combo with blood cancer drug Blenrep

24th Oct 2025 08:45

(Alliance News) - GSK PLC said Thursday its drug Blenrep has been approved by the US Food & Drug Administration for the treatment of adults with relapsed or refractory multiple myeloma, the third most common blood cancer globally. Read More

LONDON BRIEFING: UK retail sales rise; NatWest lifts 2025 guidance

24th Oct 2025 07:56

(Alliance News) - NatWest Group upgraded its 2025 guidance after reporting a strong third-quarter profit rise, while GSK secured US approval for its multiple myeloma drug Blenrep. Read More

12345678910
FTSE 100 Latest
Value9,714.96
Change13.59